The global medical simulation market revenue was around US$ 1.9 billion in 2022 and is estimated to reach US$ 7.19 billion by 2031, growing at a compound annual growth rate (CAGR) of 15.95% during the forecast period from 2023 to 2031.
Medical simulation is a teaching strategy that uses simulation models or virtual reality to let healthcare workers practice procedures and methods in real-world settings. It permits the purposeful application of clinical skills in contrast to the apprentice learning approach. A "simulation" is a made-up representation of a real-world procedure that is utilized to advance educational goals through hands-on learning. Simulation-based medical education is any training activity that mimics clinical situations using simulation tools.
Market Driving Factors
Regional Analysis
North America dominated the medical simulation market in terms of the largest share and it is anticipated to maintain this position during the projection period. It is attributed due to the rise in medical errors, the presence of significant actors, rising healthcare expenses, technological advancements, and a rise in local government activity.
However, Asia-Pacific is anticipated to witness substantial development. Due to the region's expanding population, booming number of institutions providing medical simulation services, and increasing investments. Thus, all these factors contribute to driving the market growth in this region.
Segmentation Insights
Product and Services Insights
In 2022, the healthcare anatomical model segment generated the highest revenue share. These simulators help run tests and combinations before deciding on processes, designs, or systems in the research and manufacturing sectors, particularly in the medical devices sector. These factors are expected to promote the segment's growth over the forecast period.
Technology Insights
The procedural rehearsal technology market had the largest share in 2022. It is projected that the demand for process rehearsal technology would rise because of the rise in medical errors and the resulting concern for patient safety. Efforts on technological advancements by industry players. Thus, it is anticipated to fuel market growth.
The virtual patient simulation market is estimated to expand profitably at a CAGR throughout the forecast period. The academic programs of medical colleges make use of technology in many different ways. Virtual patient simulation is a field that is occupied by companies like Simulaids, 3D Systems, Simulab Corporation, and Surgical Science Sweden AB.
Prominent Companies
Segmentation Outline
The global medical simulation market segmentation focuses on Products and Services, Technology, End-Use, and Region.
By Product and Services
By Technology
By End-Use
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL MEDICAL SIMULATION MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: MEDICAL SIMULATION MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL MEDICAL SIMULATION MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT AND SERVICES
5.1 OVERVIEW
5.2 ANATOMICAL MODELS
5.2.1 PATIENT SIMULATORS
5.2.1.1 HIGH-FIDELITY SIMULATORS
5.2.1.2 MEDIUM-FIDELITY SIMULATORS
5.2.1.3 LOW-FIDELITY SIMULATORS
5.2.2 TASK TRAINERS
5.2.3 INTERVENTIONAL/SURGICAL SIMULATORS
5.2.3.1 LAPAROSCOPIC SURGICAL SIMULATORS
5.2.3.2 GYNAECOLOGY SURGICAL SIMULATORS
5.2.3.3 CARDIAC SURGICAL SIMULATORS
5.2.3.5 ARTHROSCOPIC SURGICAL SIMULATORS
5.2.3.6 OTHER INTERVENTIONAL/SURGICAL SIMULATORS
5.2.4 ENDOVASCULAR SIMULATORS
5.2.5 ULTRASOUND SIMULATORS
5.2.6 DENTAL SIMULATORS
5.2.7 EYE SIMULATORS
5.3 WEB-BASED SIMULATION
5.4 MEDICAL SIMULATION SOFTWARE
5.4.1 PERFORMANCE RECORDING SOFTWARE
5.4.2 VIRTUAL TUTORS
5.5 SIMULATION TRAINING SERVICES
5.5.1 VENDOR-BASED TRAINING
5.5.2 EDUCATIONAL SOCIETIES
5.5.3 CUSTOM CONSULTING AND TRAINING SERVICES
6 GLOBAL MEDICAL SIMULATION MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 VIRTUAL PATIENT SIMULATION
6.3 3D PRINTING
6.4 PROCEDURE REHEARSAL TECHNOLOGY
7 GLOBAL MEDICAL SIMULATION MARKET, BY END-USE
7.1 OVERVIEW
7.2 ACADEMIC INSTITUTES
7.3 HOSPITALS
7.4 MILITARY ORGANIZATIONS
7.5 RESEARCH
7.5.1 MEDICAL DEVICE COMPANIES
7.5.2 OTHERS
8 GLOBAL MEDICAL SIMULATION MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL MEDICAL SIMULATION MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 CAE HEALTHCARE INC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 SIMULAB CORPORATION
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 3D SYSTEMS, INC
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 CARDIONICS
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 SIMULAIDS
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 MENTICE
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 LAERDAL MEDICAL
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 KYOTO KAGAKU CO LTD
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 GAUMARD SCIENTIFIC
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 INTELLIGENT ULTRASOUND (MEDAPHOR LTD.)
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 LIMBS & THINGS LTD
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
著作権 ©2022 無断複写・転載を禁じます